Back
VAALCO Energy 10K Form
Sell
33
EGY
VAALCO Energy
Last Price:
5.16
Seasonality Move:
15.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | EGY/VAALCO Energy Quarterly |
| 2023-11-08 | 10Q | EGY/VAALCO Energy Quarterly |
| 2023-08-09 | 10Q | EGY/VAALCO Energy Quarterly |
| 2023-05-10 | 10Q | EGY/VAALCO Energy Quarterly |
| 2022-11-08 | 10Q | EGY/VAALCO Energy Quarterly |
| 2022-08-10 | 10Q | EGY/VAALCO Energy Quarterly |
Receive EGY News And Ratings
See the #1 stock for the next 7 days that we like better than EGY
EGY Financial Statistics
Sales & Book Value
| Annual Sales: | $455.07M |
|---|---|
| Cash Flow: | $35.36M |
| Price / Cash Flow: | 13.49 |
| Annual Sales: | $4.83 |
| Price / Book: | 1.06 |
Profitability
| EPS (TTM): | 0.85000 |
|---|---|
| Net Income (TTM): | $90.82M |
| Gross Margin: | $186.61M |
| Return on Equity: | 19% |
| Return on Assets: | 10.52% |
VAALCO Energy Earnings Forecast
Key VAALCO Energy Financial Ratios
- The Gross Profit Margin over the past 34 years for EGY is 41.01%.
- The Selling, General & Administrative Expenses for EGY have been equal to 5.24% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 3.92% of Operating Income.
- The Net Earning history of EGY is 13.26% of Total Revenues.
- Per Share Earnings over the last 34 years have been positive in 20 years.
VAALCO Energy Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | EGY |
| CUSIP: | 91851C |
| Website: | vaalco.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.34 |
| Quick Ratio: | 1.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 9.14 |
|---|---|
| Forward P/E Ratio: | 13.3 |
EGY Technical Analysis vs Fundamental Analysis
Sell
33
VAALCO Energy (EGY)
is a Sell
Is VAALCO Energy a Buy or a Sell?
-
VAALCO Energy stock is rated a Sell
The current VAALCO Energy [EGY] share price is $5.12. The Score for EGY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.